Complement in animal development: Unexpected roles of a highly conserved pathway

Seminars in Immunology

Volumn 25, Issue 1, 2013, Pages 39-46

  Leslie, Jonathan D ^a   Mayor, Roberto ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

Chemotaxis; Co attraction; Collective cell migration; Complement; Development; Synapse elimination

Indexed keywords

COMPLEMENT;

CELL MIGRATION; COMPLEMENT ALTERNATIVE PATHWAY; COMPLEMENT CLASSICAL PATHWAY; COMPLEMENT SYSTEM; HUMAN; IMMUNOSURVEILLANCE; INNATE IMMUNITY; MORPHOGENESIS; NEURAL CREST CELL; NONHUMAN; REGENERATION; REVIEW; SIGNAL TRANSDUCTION; SYNAPSE;

CHEMOTAXIS; CO-ATTRACTION; COLLECTIVE CELL MIGRATION; COMPLEMENT; DEVELOPMENT; SYNAPSE ELIMINATION;

ANIMALS; CELL COMMUNICATION; CELL MOVEMENT; COMPLEMENT SYSTEM PROTEINS; ELECTRICAL SYNAPSES; HUMANS; IMMUNOLOGIC SURVEILLANCE; MORPHOGENESIS; REGENERATION; SIGNAL TRANSDUCTION;

EID: 84879886775     PISSN: 10445323     EISSN: 10963618     Source Type: Journal    
DOI: 10.1016/j.smim.2013.04.005     Document Type: Review

References (98)

1. Hoffmann J.A. Phylogenetic perspectives in innate immunity. Science 1999, 284:1313-1318.
2. Muller W.E., Blumbach B., Muller I.M. Evolution of the innate and adaptive immune systems: relationships between potential immune molecules in the lowest metazoan phylum (Porifera) and those in vertebrates. Transplantation 1999, 68:1215-1227.
3. Zarkadis I.K., Mastellos D., Lambris J.D. Phylogenetic aspects of the complement system. Developmental & Comparative Immunology 2001, 25:745-762.
4. Ricklin D., Hajishengallis G., Yang K., Lambris J.D. Complement: a key system for immune surveillance and homeostasis. Nature Immunology 2010, 11:785-797.
5. Tegla C.A., Cudrici C., Patel S., Trippe R., Rus V., Niculescu F., et al. Membrane attack by complement: the assembly and biology of terminal complement complexes. Immunologic Research 2011, 51:45-60.
6. Cole D.S., Morgan B.P. Beyond lysis: how complement influences cell fate. Clinical Science (London) 2003, 104:455-466.
7. Stephan A.H., Barres B.A., Stevens B. The complement system: an unexpected role in synaptic pruning during development and disease. Annual Review of Neuroscience 2012, 35:369-389.
8. Low L.K., Cheng H.J. A little nip and tuck: axon refinement during development and axonal injury. Current Opinion in Neurobiology 2005, 15:549-556.
9. Luo L., O'Leary D.D. Axon retraction and degeneration in development and disease. Annual Review of Neuroscience 2005, 28:127-156.
10. McLin V.A., Hu C.H., Shah R., Jamrich M. Expression of complement components coincides with early patterning and organogenesis in Xenopus laevis. International Journal of Developmental Biology 2008, 52:1123-1133.
11. Pollet N., Muncke N., Verbeek B., Li Y., Fenger U., Delius H., et al. An atlas of differential gene expression during early Xenopus embryogenesis. Mechanisms of Development 2005, 122:365-439.
12. Carmona-Fontaine C., Theveneau E., Tzekou A., Tada M., Woods M., Page K.M., et al. Complement fragment C3a controls mutual cell attraction during collective cell migration. Developmental Cell 2011, 21:1026-1037.
13. Stevens B., Allen N.J., Vazquez L.E., Howell G.R., Christopherson K.S., Nouri N., et al. The classical complement cascade mediates CNS synapse elimination. Cell 2007, 131:1164-1178.
14. Denny K.J., Coulthard L.G., Jeanes A., Lisgo S., Simmons D.G., Callaway L.K., et al. C5a receptor signaling prevents folate deficiency-induced neural tube defects in mice. Journal of Immunology 2013, 190:3493-3499.
15. Rooryck C., Diaz-Font A., Osborn D.P., Chabchoub E., Hernandez-Hernandez V., Shamseldin H., et al. Mutations in lectin complement pathway genes COLEC11 and MASP1 cause 3MC syndrome. Nature Genetics 2011, 43:197-203.
16. Degn S.E., Jensenius J.C., Thiel S. Disease-causing mutations in genes of the complement system. American Journal of Human Genetics 2011, 88:689-705.
17. Sirmaci A., Walsh T., Akay H., Spiliopoulos M., Sakalar Y.B., Hasanefendioglu-Bayrak A., et al. MASP1 mutations in patients with facial, umbilical, coccygeal, and auditory findings of Carnevale, Malpuech, OSA, and Michels syndromes. American Journal of Human Genetics 2010, 87:679-686.
18. Lampson L.A. Interpreting MHC class I expression and class I/class II reciprocity in the CNS: reconciling divergent findings. Microscopy Research and Technique 1995, 32:267-285.
19. Boulanger L.M., Shatz C.J. Immune signalling in neural development, synaptic plasticity and disease. Nature Reviews Neuroscience 2004, 5:521-531.
20. Boulanger L.M. Immune proteins in brain development and synaptic plasticity. Neuron 2009, 64:93-109.
21. Carpentier P.A., Palmer T.D. Immune influence on adult neural stem cell regulation and function. Neuron 2009, 64:79-92.
22. Deverman B.E., Patterson P.H. Cytokines and CNS development. Neuron 2009, 64:61-78.
23. Garay P.A., McAllister A.K. Novel roles for immune molecules in neural development: implications for neurodevelopmental disorders. Frontiers in Synaptic Neuroscience 2010, 2:136.
24. Corriveau R.A., Huh G.S., Shatz C.J. Regulation of class I MHC gene expression in the developing and mature CNS by neural activity. Neuron 1998, 21:505-520.
25. Huh G.S., Boulanger L.M., Du H., Riquelme P.A., Brotz T.M., Shatz C.J. Functional requirement for class I MHC in CNS development and plasticity. Science 2000, 290:2155-2159.
26. Boulanger L.M., Huh G.S., Shatz C.J. Neuronal plasticity and cellular immunity: shared molecular mechanisms. Current Opinion in Neurobiology 2001, 11:568-578.
27. Scorisa J.M., Freria C.M., Victorio S.C., Barbizan R., Zanon R.G., Oliveira A.L. Glatiramer acetate treatment increases stability of spinal synapses and down regulates MHC I during the course of EAE. International Journal of Biological Sciences 2011, 7:1188-1202.
28. Bjartmar L., Huberman A.D., Ullian E.M., Renteria R.C., Liu X., Xu W., et al. Neuronal pentraxins mediate synaptic refinement in the developing visual system. Journal of Neuroscience 2006, 26:6269-6281.
29. Shatz C.J. MHC class I: an unexpected role in neuronal plasticity. Neuron 2009, 64:40-45.
30. Sretavan D., Shatz C.J. Prenatal development of individual retinogeniculate axons during the period of segregation. Nature 1984, 308:845-848.
31. Campbell G., Shatz C.J. Synapses formed by identified retinogeniculate axons during the segregation of eye input. Journal of Neuroscience 1992, 12:1847-1858.
32. Howell G.R., Macalinao D.G., Sousa G.L., Walden M., Soto I., Kneeland S.C., et al. Molecular clustering identifies complement and endothelin induction as early events in a mouse model of glaucoma. Journal of Clinical Investigation 2011, 121:1429-1444.
33. Chu Y., Jin X., Parada I., Pesic A., Stevens B., Barres B., et al. Enhanced synaptic connectivity and epilepsy in C1q knockout mice. Proceedings of the National Academy of Sciences of the United States of America 2010, 107:7975-7980.
34. Rosen A.M., Stevens B. The role of the classical complement cascade in synapse loss during development and glaucoma. Advances in Experimental Medicine and Biology 2010, 703:75-93.
35. Cowell R.M., Plane J.M., Silverstein F.S. Complement activation contributes to hypoxic-ischemic brain injury in neonatal rats. Journal of Neuroscience 2003, 23:9459-9468.
36. Schafer D.P., Lehrman E.K., Kautzman A.G., Koyama R., Mardinly A.R., Yamasaki R., et al. Microglia sculpt postnatal neural circuits in an activity and complement-dependent manner. Neuron 2012, 74:691-705.
37. Stasi K., Nagel D., Yang X., Wang R.F., Ren L., Podos S.M., et al. Complement component 1Q (C1Q) upregulation in retina of murine, primate, and human glaucomatous eyes. Investigative Ophthalmology and Visual Science 2006, 47:1024-1029.
38. Schafer M.K., Schwaeble W.J., Post C., Salvati P., Calabresi M., Sim R.B., et al. Complement C1q is dramatically up-regulated in brain microglia in response to transient global cerebral ischemia. Journal of Immunology 2000, 164:5446-5452.
39. Theveneau E., Mayor R. Collective cell migration of epithelial and mesenchymal cells. Cellular and Molecular Life Sciences 2013, in press. 10.1007/s00018-012-1251-7.
40. Theveneau E., Mayor R. Integrating chemotaxis and contact-inhibition during collective cell migration: small GTPases at work. Small GTPases 2010, 1:113-117.
41. Friedl P., Gilmour D. Collective cell migration in morphogenesis, regeneration and cancer. Nature Reviews Molecular Cell Biology 2009, 10:445-457.
42. Carmona-Fontaine C., Matthews H.K., Kuriyama S., Moreno M., Dunn G.A., Parsons M., et al. Contact inhibition of locomotion in vivo controls neural crest directional migration. Nature 2008, 456:957-961.
43. Theveneau E., Marchant L., Kuriyama S., Gull M., Moepps B., Parsons M., et al. Collective chemotaxis requires contact-dependent cell polarity. Developmental Cell 2010, 19:39-53.
44. Theveneau E., Mayor R. Neural crest delamination and migration: from epithelium-to-mesenchyme transition to collective cell migration. Developmental Biology 2012, 366:34-54.
45. Trainor P.A. Specification of neural crest cell formation and migration in mouse embryos. Seminars in Cell and Developmental Biology 2005, 16:683-693.
46. Mayor R., Carmona-Fontaine C. Keeping in touch with contact inhibition of locomotion. Trends in Cell Biology 2010, 20:319-328.
47. Abercrombie M., Heaysman J.E. Observations on the social behaviour of cells in tissue culture. I. Speed of movement of chick heart fibroblasts in relation to their mutual contacts. Experimental Cell Research 1953, 5:111-131.
48. Abercrombie M., Dunn G.A. Adhesions of fibroblasts to substratum during contact inhibition observed by interference reflection microscopy. Experimental Cell Research 1975, 92:57-62.
49. Ridley A.J., Paterson H.F., Johnston C.L., Diekmann D., Hall A. The small GTP-binding protein rac regulates growth factor-induced membrane ruffling. Cell 1992, 70:401-410.
50. Matthews H.K., Marchant L., Carmona-Fontaine C., Kuriyama S., Larrain J., Holt M.R., et al. Directional migration of neural crest cells in vivo is regulated by Syndecan-4/Rac1 and non-canonical Wnt signaling/RhoA. Development 2008, 135:1771-1780.
51. Shinjyo N., Stahlberg A., Dragunow M., Pekny M., Pekna M. Complement-derived anaphylatoxin C3a regulates in vitro differentiation and migration of neural progenitor cells. Stem Cells 2009, 27:2824-2832.
52. Leal G.F., Silva E.O., Duarte A.R., Campos J.F. Blepharophimosis, blepharoptosis, defects of the anterior chamber of the eye, caudal appendage, radioulnar synostosis, hearing loss and umbilical anomalies in sibs: 3MC syndrome?. American Journal of Medical Genetics Part A 2008, 146A:1059-1062.
53. Al Kaissi A., Klaushofer K., Safi H., Chehida F.B., Ghachem M.B., Chaabounni M., et al. Asymmetrical skull, ptosis, hypertelorism, high nasal bridge, clefting, umbilical anomalies, and skeletal anomalies in sibs: is Carnevale syndrome a separate entity?. American Journal of Medical Genetics Part A 2007, 143:349-354.
54. Dahl M.R., Thiel S., Matsushita M., Fujita T., Willis A.C., Christensen T., et al. MASP-3 and its association with distinct complexes of the mannan-binding lectin complement activation pathway. Immunity 2001, 15:127-135.
55. Keshi H., Sakamoto T., Kawai T., Ohtani K., Katoh T., Jang S.J., et al. Identification and characterization of a novel human collectin CL-K1. Microbiology and Immunology 2006, 50:1001-1013.
56. Ohtani K., Suzuki Y., Wakamiya N. Biological functions of the novel collectins CL-L1, CL-K1, and CL-P1. Journal of Biomedicine and Biotechnology 2012, 2012:493945.
57. Zundel S., Cseh S., Lacroix M., Dahl M.R., Matsushita M., Andrieu J.P., et al. Characterization of recombinant mannan-binding lectin-associated serine protease (MASP)-3 suggests an activation mechanism different from that of MASP-1 and MASP-2. Journal of Immunology 2004, 172:4342-4350.
58. Kurihara R., Yamaoka K., Sawamukai N., Shimajiri S., Oshita K., Yukawa S., et al. C5a promotes migration, proliferation, and vessel formation in endothelial cells. Inflammation Research 2010, 59:659-666.
59. Biesecker G. The complement SC5b-9 complex mediates cell adhesion through a vitronectin receptor. Journal of Immunology 1990, 145:209-214.
60. Hautanen A., Keski-Oja J. Interaction of fibronectin with complement component C3. Scandinavian Journal of Immunology 1983, 17:225-230.
61. Leivo I., Engvall E. C3d fragment of complement interacts with laminin and binds to basement membranes of glomerulus and trophoblast. The Journal of Cell Biology 1986, 103:1091-1100.
62. Lander A.D. How cells know where they are. Science 2013, 339:923-927.
63. Legoedec J., Gasque P., Jeanne J.F., Fontaine M. Expression of the complement alternative pathway by human myoblasts in vitro: biosynthesis of C3, factor B, factor H and factor I. European Journal of Immunology 1995, 25:3460-3466.
64. Legoedec J., Gasque P., Jeanne J.F., Scotte M., Fontaine M. Complement classical pathway expression by human skeletal myoblasts in vitro. Molecular Immunology 1997, 34:735-741.
65. Del Rio-Tsonis K., Tsonis P.A., Zarkadis I.K., Tsagas A.G., Lambris J.D. Expression of the third component of complement, C3, in regenerating limb blastema cells of urodeles. Journal of Immunology 1998, 161:6819-6824.
66. da Silva S.M., Gates P.B., Brockes J.P. The newt ortholog of CD59 is implicated in proximodistal identity during amphibian limb regeneration. Developmental Cell 2002, 3:547-555.
67. Kimura Y., Madhavan M., Call M.K., Tsonis P.A., Lambris J.D., Rio-Tsonis D. Expression of complement 3 and complement 5 in newt limb and lens regeneration. Journal of Immunology 2003, 170:2331-2339.
68. Mastellos D., Papadimitriou J.C., Franchini S., Tsonis P.A., Lambris J.D. A novel role of complement: mice deficient in the fifth component of complement (C5) exhibit impaired liver regeneration. Journal of Immunology 2001, 166:2479-2486.
69. Strey C.W., Markiewski M., Mastellos D., Tudoran R., Spruce L.A., Greenbaum L.E., et al. The proinflammatory mediators C3a and C5a are essential for liver regeneration. Journal of Experimental Medicine 2003, 198:913-923.
70. He S., Atkinson C., Qiao F., Cianflone K., Chen X., Tomlinson S. A complement-dependent balance between hepatic ischemia/reperfusion injury and liver regeneration in mice. Journal of Clinical Investigation 2009, 119:2304-2316.
71. Markiewski M.M., DeAngelis R.A., Strey C.W., Foukas P.G., Gerard C., Gerard N., et al. The regulation of liver cell survival by complement. Journal of Immunology 2009, 182:5412-5418.
72. Clark A., Weymann A., Hartman E., Turmelle Y., Carroll M., Thurman J.M., et al. Evidence for non-traditional activation of complement factor C3 during murine liver regeneration. Molecular Immunology 2008, 45:3125-3132.
73. Zhang X., Kimura Y., Fang C., Zhou L., Sfyroera G., Lambris J.D., et al. Regulation of Toll-like receptor-mediated inflammatory response by complement in vivo. Blood 2007, 110:228-236.
74. Kraus S., Seger R., Fishelson Z. Involvement of the ERK mitogen-activated protein kinase in cell resistance to complement-mediated lysis. Clinical and Experimental Immunology 2001, 123:366-374.
75. Peng H., Takano T., Papillon J., Bijian K., Khadir A., Cybulsky A.V. Complement activates the c-Jun N-terminal kinase/stress-activated protein kinase in glomerular epithelial cells. Journal of Immunology 2002, 169:2594-2601.
76. Rus H., Niculescu F., Badea T., Shin M.L. Terminal complement complexes induce cell cycle entry in oligodendrocytes through mitogen activated protein kinase pathway. Immunopharmacology 1997, 38:177-187.
77. Rus H.G., Niculescu F., Shin M.L. Sublytic complement attack induces cell cycle in oligodendrocytes. Journal of Immunology 1996, 156:4892-4900.
78. Niculescu F., Badea T., Rus H. Sublytic C5b-9 induces proliferation of human aortic smooth muscle cells: role of mitogen activated protein kinase and phosphatidylinositol 3-kinase. Atherosclerosis 1999, 142:47-56.
79. Qiu W., Zhang Y., Liu X., Zhou J., Li Y., Zhou Y., et al. Sublytic C5b-9 complexes induce proliferative changes of glomerular mesangial cells in rat Thy-1 nephritis through TRAF6-mediated PI3K-dependent Akt1 activation. Journal of Pathology 2012, 226:619-632.
80. Gao L., Zhang Y., Qiu W., Xu W., Feng X., Ren J., et al. Effects of PI3-k/Akt short hairpin RNA on proliferation, fibronectin production and synthesis of thrombospondin-1 and transforming growth factor-beta1 in glomerular mesangial cells induced by sublytic C5b-9 complexes. Cell Proliferation 2009, 42:83-93.
81. Shankland S.J., Pippin J.W., Couser W.G. Complement (C5b-9) induces glomerular epithelial cell DNA synthesis but not proliferation in vitro. Kidney International 1999, 56:538-548.
82. O'Barr S.A., Caguioa J., Gruol D., Perkins G., Ember J.A., Hugli T., et al. Neuronal expression of a functional receptor for the C5a complement activation fragment. Journal of Immunology 2001, 166:4154-4162.
83. Vlaicu S.I., Tegla C.A., Cudrici C.D., Danoff J., Madani H., Sugarman A., et al. Role of C5b-9 complement complex and response gene to complement-32 (RGC-32) in cancer. Immunologic Research 2013, 56(1):109-121.
84. Liu L., Qiu W., Wang H., Li Y., Zhou J., Xia M., et al. Sublytic C5b-9 complexes induce apoptosis of glomerular mesangial cells in rats with Thy-1 nephritis through role of interferon regulatory factor-1-dependent caspase 8 activation. Journal of Biological Chemistry 2012, 287:16410-16423.
85. Qiu W., Che N., Feng X., Xia M., Wang H., Zhao D., et al. Apoptosis of glomerular mesangial cells induced by sublytic C5b-9 complexes in rats with Thy-1 nephritis is dependent on Gadd45 gamma upregulation. European Journal of Immunology 2009, 39:3251-3266.
86. Jiang X., Zhang J., Xia M., Qiu W., Wang H., Zhao D., et al. Role of activating transcription factor 3 (ATF3) in sublytic C5b-9-induced glomerular mesangial cell apoptosis. Cellular & Molecular Immunology 2010, 7:143-151.
87. Farkas I., Baranyi L., Liposits Z.S., Yamamoto T., Complement Okada H. C5a anaphylatoxin fragment causes apoptosis in TGW neuroblastoma cells. Neuroscience 1998, 86:903-911.
88. Farkas I., Baranyi L., Takahashi M., Fukuda A., Liposits Z., Yamamoto T., et al. A neuronal C5a receptor and an associated apoptotic signal transduction pathway. Journal of Physiology 1998, 507(Pt 3):679-687.
89. Guo R.F., Huber-Lang M., Wang X., Sarma V., Padgaonkar V.A., Craig R.A., et al. Protective effects of anti-C5a in sepsis-induced thymocyte apoptosis. The Journal of Clinical Investigation 2000, 106:1271-1280.
90. Riedemann N.C., Guo R.F., Neff T.A., Laudes I.J., Keller K.A., Sarma V.J., et al. Increased C5a receptor expression in sepsis. Journal of Clinical Investigation 2002, 110:101-108.
91. Guo R.F., Riedemann N.C., Ward P.A. Role of C5a-C5aR interaction in sepsis. Shock 2004, 21:1-7.
92. Riedemann N.C., Guo R.F., Laudes I.J., Keller K., Sarma V.J., Padgaonkar V., et al. C5a receptor and thymocyte apoptosis in sepsis. FASEB Journal 2002, 16:887-888.
93. Jacob A., Hack B., Chen P., Quigg R.J., Alexander J.J. C5a/CD88 signaling alters blood-brain barrier integrity in lupus through nuclear factor-kappaB. Journal of Neurochemistry 2011, 119:1041-1051.
94. Kilgore K.S., Schmid E., Shanley T.P., Flory C.M., Maheswari V., Tramontini N.L., et al. Sublytic concentrations of the membrane attack complex of complement induce endothelial interleukin-8 and monocyte chemoattractant protein-1 through nuclear factor-kappa B activation. American Journal of Pathology 1997, 150:2019-2031.
95. Viedt C., Hansch G.M., Brandes R.P., Kubler W., Kreuzer J. The terminal complement complex C5b-9 stimulates interleukin-6 production in human smooth muscle cells through activation of transcription factors NF-kappa B and AP-1. FASEB Journal 2000, 14:2370-2372.
96. Naito A.T., Sumida T., Nomura S., Liu M.L., Higo T., Nakagawa A., et al. Complement C1q activates canonical Wnt signaling and promotes aging-related phenotypes. Cell 2012, 149:1298-1313.
97. Liu H., Fergusson M.M., Castilho R.M., Liu J., Cao L., Chen J., et al. Augmented Wnt signaling in a mammalian model of accelerated aging. Science 2007, 317:803-806.
98. Brack A.S., Conboy M.J., Roy S., Lee M., Kuo C.J., Keller C., et al. Increased Wnt signaling during aging alters muscle stem cell fate and increases fibrosis. Science 2007, 317:807-810.